Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide
- PMID: 21801426
- PMCID: PMC3199744
- DOI: 10.1186/1742-6405-8-27
Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide
Abstract
Background: RC-101, a cationic peptide retrocyclin analog, has in vitro activity against HIV-1. Peptide drugs are commonly prone to conformational changes, oxidation and hydrolysis when exposed to excipients in a formulation or biological fluids in the body, this can affect product efficacy. We aimed to investigate RC-101 stability under several conditions including the presence of human vaginal fluids (HVF), enabling the efficient design of a safe and effective microbicide product. Stability studies (temperature, pH, and oxidation) were performed by HPLC, Circular Dichroism, and Mass Spectrometry (LC-MS/MS). Additionally, the effect of HVF on formulated RC-101 was evaluated with fluids collected from healthy volunteers, or from subjects with bacterial vaginosis (BV). RC-101 was monitored by LC-MS/MS for up to 72 h.
Results: RC-101 was stable at pH 3, 4, and 7, at 25 and 37°C. High concentrations of hydrogen peroxide resulted in less than 10% RC-101 reduction over 24 h. RC-101 was detected 48 h after incubation with normal HVF; however, not following incubation with HVF from BV subjects.
Conclusions: Our results emphasize the importance of preformulation evaluations and highlight the impact of HVF on microbicide product stability and efficacy. RC-101 was stable in normal HVF for at least 48 h, indicating that it is a promising candidate for microbicide product development. However, RC-101 stability appears compromised in individuals with BV, requiring more advanced formulation strategies for stabilization in this environment.
Figures




Similar articles
-
Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.Antimicrob Agents Chemother. 2011 May;55(5):2282-9. doi: 10.1128/AAC.01190-10. Epub 2011 Feb 14. Antimicrob Agents Chemother. 2011. PMID: 21321138 Free PMC article.
-
A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.Front Microbiol. 2022 Mar 23;13:806654. doi: 10.3389/fmicb.2022.806654. eCollection 2022. Front Microbiol. 2022. PMID: 35444633 Free PMC article.
-
Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.J Pharm Innov. 2017 Jun;12(2):142-154. doi: 10.1007/s12247-017-9274-0. Epub 2017 Mar 3. J Pharm Innov. 2017. PMID: 28983328 Free PMC article.
-
Current Concepts for the IND-Directed Development of Microbicide Products to Prevent the Sexual Transmission of HIV.Curr Top Med Chem. 2016;16(10):1118-34. doi: 10.2174/1568026615666150901113939. Curr Top Med Chem. 2016. PMID: 26324047 Review.
-
Clinical development of microbicides for the prevention of HIV infection.Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374. Curr Pharm Des. 2004. PMID: 14754390 Review.
Cited by
-
Defensins: defenders of human reproductive health.Hum Reprod Update. 2023 Jan 5;29(1):126-154. doi: 10.1093/humupd/dmac032. Hum Reprod Update. 2023. PMID: 36130055 Free PMC article. Review.
-
Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa.Ann Clin Microbiol Antimicrob. 2016 Mar 11;15:16. doi: 10.1186/s12941-016-0132-6. Ann Clin Microbiol Antimicrob. 2016. PMID: 26968525 Free PMC article. Review.
-
Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.J Antimicrob Chemother. 2012 Dec;67(12):2870-2. doi: 10.1093/jac/dks305. Epub 2012 Jul 31. J Antimicrob Chemother. 2012. PMID: 22855857 Free PMC article.
-
The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa.Antibiotics (Basel). 2014 Nov 26;3(4):677-93. doi: 10.3390/antibiotics3040677. Antibiotics (Basel). 2014. PMID: 27025760 Free PMC article. Review.
-
Retrocyclins neutralize bacterial toxins by potentiating their unfolding.Biochem J. 2015 Apr 15;467(2):311-20. doi: 10.1042/BJ20150049. Biochem J. 2015. PMID: 25670244 Free PMC article.
References
-
- AIDS epidemic update. UNAIDS: WHO Library Cataloguing-in-Publication Data; 2009.
-
- MDS Working Groups - Alliance for Microbicide Development. Silver Spring, MD: Alliance for Microbicide Development; 2006. The Microbicide Development Strategy.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources